AlphAIalphai — Financial news for AI agents
finance.yahoo.comJUN 24 min read$MDB

UBS Raises PT On MongoDB (MDB) To $350, Maintains “Neutral” Rating

MongoDB reported Q1 FY2027 revenue of $687.6M (+25% YoY) and non-GAAP EPS of $1.32. Subscription revenue rose 25% to $666.1M; free cash flow was $197.5M. RPO increased 88% to $1.46B. Guidance: Q2 revenue $729M–$734M; FY2027 revenue raised to $2.92B–$2.96B. UBS raised its PT to $350 and kept a Neutral rating.

Original reporting
finance.yahoo.com
Published Jun 2, 2026, 10:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 10:48 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
UBS Raises PT On MongoDB (MDB) To $350, Maintains “Neutral” Rating — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$MDBNeutralMed
01

Why it matters

UBS’s PT hike acknowledges stronger operating performance and guidance, while the Neutral rating suggests valuation/upside is not compelling enough to turn bullish.

02

Market read

This is a post-earnings valuation recalibration: PT rises with fundamentals, but the unchanged Neutral rating signals limited incremental conviction.

03

What to watch

Near-term tape may hinge more on whether raised FY guidance and RPO momentum translate into sustained subscription growth beyond Q2.

Relevance 9/10Novelty 7/10Timing: post-earnings analyst note (UBS PT change dated May 29, 2026)

Background

MongoDB reported fiscal Q1 2027 results (revenue +25% YoY, non-GAAP EPS $1.32) and raised FY revenue guidance; it also highlighted AI-related partnerships and a federal vertical acquisition.

Company-level read

Ticker impact

$MDBNeutralMedium confidence
Context

UBS raised MongoDB’s price target to $350 and kept a Neutral rating after its fiscal Q1 revenue/EPS and raised FY guidance.

Expected impact

Likely modest support for the stock on PT headline, but Neutral rating caps upside follow-through.

Evidence & confidence

The article’s actionable change is UBS PT revision; however, the rating remains Neutral and UBS cites results driven mainly by core business vs early AI demand.

Market effects

Sector

Reinforces “enterprise data platform + AI agent backend” narrative for SaaS/data infrastructure names, but with caution on AI-demand timing.

Regional

Limited; primarily US-listed SaaS sentiment.

Global

Low; company-specific analyst/PT update rather than macro or global policy shift.

Counterpoint

What could challenge this read

If investors were expecting AI-driven acceleration, UBS’s emphasis on core business could reduce enthusiasm and mute any PT-driven rally.

Key entities

  • company
    MongoDB, Inc.

    Developer data platform company; subject of UBS PT change and its own quarter/guidance.

  • analyst_firm
    UBS

    Raised MDB price target to $350 from $275; maintained Neutral rating.

Read at source← All news

Related articles

JUN 5
$MDBMedAI 9/10

MongoDB Is the Latest SaaS Apocalypse Victim to Say Not Today

MongoDB shares rose nearly 40% from pre-earnings levels after the company’s blowout earnings report last week, which the article says beat expectations across key metrics and reduced concerns that AI would hurt growth. It also notes analysts raised price targets afterward, with some projecting about 20% additional upside from current levels.

finance.yahoo.com6 min
JUN 2
$MDBMedAI 9/10

MongoDB (MDB) Soars 20.4% as UBS Raises PT by Double-Digits

MongoDB shares rose 20.36% to close at $403.88 on Monday, extending a three-day winning streak. UBS raised its price target 27% to $350 from $275 while keeping a neutral rating. UBS cited MongoDB’s Q1 FY2027 shift to profit of $4.4M and revenue up 25% to $687.6M; MongoDB guided Q2 revenue to $729M–$734M.

finance.yahoo.com4 min
JUN 1
$MDBMedAI 9/10

MongoDB (MDB) Stock Trades Up, Here Is Why

MongoDB shares rose 17.9% in the afternoon after its May 28 earnings beat and a broader software-sector rotation, according to the article. For Q1 FY2027, revenue was $687.6M (+25% YoY) vs. $664.5M expected; adjusted EPS was $1.32 vs. $1.19. Atlas revenue grew 29.4% to $512.5M; free cash flow was $197.5M. Guidance was raised to $2.92–$2.96B revenue and $5.95–$6.14 EPS.

markets.financialcontent.com4 min
MAY 31
$SNOWMedAI 9/10

Software Was the Market's Big Laggard This Year. Snowflake's Blowout Might Be the Spark That Changes That.

Software stocks lagged early 2026 despite gains in the S&P 500, and Snowflake shares fell more than 50% from a year earlier in April. After fiscal Q1 ended April 30, Snowflake reported product revenue up 34% to $1.33B, non-GAAP operating margin rising to 12%, and EPS of $0.39. Management lifted full-year product revenue guidance to $5.84B and said AI is increasing data/workload consumption; Datadog and MongoDB also reported accelerating results.

fool.com6 min
MAY 30
$MDBMedAI 8/10

Cantor Fitzgerald Raises MongoDB (MDB) Price Target on Stable Outlook and AI Demand

Cantor Fitzgerald analyst Thomas Blakey raised MongoDB’s (MDB) price target to $416 from $378 and kept an Overweight rating, citing channel checks showing last quarter’s results were broadly in line and a stable forward outlook supported by AI demand. Separately, BMO Capital analyst Keith Bachman lifted his target to $360 from $285 with an Outperform rating, saying MongoDB is well positioned for durable long-term growth in AI workloads.

finance.yahoo.com3 min